By Nigam Arora & Dr. Natasha Arora
Editors Note: Our goal is to help investors maximize their wealth generation. The purpose of this post is solely to convey an investment opportunity.
Signal(s) to enter, add, reduce, exit, hold or change.
Transgender Controversy
BUD stock has fallen significantly since a transgender influencer promoted Bud Light. The stock is now trading at $53.22. The 52-week high is $67.09.
If history is any guide, the boycott of BUD will fizzle out.
BUD seems to be correcting the course in advertising.
Buy Zone
For those following the Good Way, the Buy Now rating is 🔒 (To see the locked content, please take a 30 day free trial).
For those following the Best Way, consider accumulating BUD over a wide buy zone of 🔒. Consider very small tranches near the high band of the buy zone and bigger tranches if it falls closer to the low end of the buy zone.
The recommended quantity is 🔒 of the full core position size.
This is a very long term position. The very long term target zone is 🔒.
An Additional Opportunity
In addition to buying BUD on the long side, there is also an opportunity to short Molson Coors (TAP). TAP has benefited from BUD’s trouble. Expect a mean reversion in due course.
For the short zone and more details, please see ZYX Short.
Pair It
For those with sophistication, it is best to pair the long trade on BUD with the short trade on TAP.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
